- QMRO Home
- William Harvey Research Institute
- Centre for Experimental Medicine and Rheumatology (EMR)
- RANDOMISED, OPEN LABELLED CLINICAL TRIAL TO INVESTIGATE SYNOVIAL MECHANISMS DETERMINING RESPONSE: RESISTANCE TO RITUXIMAB VERSUS TOCILIZUMAB IN RA PATIENTS FAILING TNF INHIBITOR THERAPY
Browse
Administrators only